ConvergEx’s monthly review of analysts’ revenue expectations for the 30 companies in the Dow finds a ray of sunshine (let’s call them ‘sweet dreams’) to counter the current humdrum market action. First, the ‘good’ news: analysts expect the current quarter to post some of the best top line growth in over 2 years.